Comparison of gene expression and DNA copy number changes in a murine model of lung cancer

Genes Chromosomes and Cancer

Volumn 45, Issue 4, 2006, Pages 338-348

  Sweet Cordero, Alejandro ^a,d,e,f   Tseng, George C ^b   You, Han ^a   Douglass, Margaret ^a   Huey, Bing ^c   Albertson, Donna ^c   Jacks, Tyler ^a,g  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Bld E17 517 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MODEL; CHROMOSOME 11; CHROMOSOME 16; CHROMOSOME 17; CHROMOSOME 19; CHROMOSOME 4; CHROMOSOME 6; CHROMOSOME 8; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; CONTROLLED STUDY; DNA DAMAGE; DNA SEQUENCE; GENE ACTIVATION; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENOME; LUNG CANCER; MOUSE; NONHUMAN; ONCOGENE K RAS; PRIORITY JOURNAL; TELOMERE;

ANIMALS; CHROMOSOMES, ARTIFICIAL, BACTERIAL; DATABASES, GENETIC; DISEASE MODELS, ANIMAL; GENE DELETION; GENE DOSAGE; GENE DUPLICATION; GENE EXPRESSION; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

ANIMALIA; MURINAE;

EID: 33644746131     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20296     Document Type: Article

References (27)

1. Albertson DG, Ylstra B, Segraves R, Collins C, Dairkee SH, Kowbel D, Kuo WL, Gray JW, Pinkel D. 2000. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet 25(2):144-146.
2. Balsara BR, Sonoda G, du Manoir S, Siegfried JM, Gabrielson E, Testa JR. 1997. Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas. Cancer Res 57:2116-2120.
3. Balsara BR, Testa JR. 2002. Chromosomal imbalances in human lung cancer. Oncogene 21:6877-6883.
4. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D. 2000. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2:737-744.
5. Bonner AE, Lemon WJ, Devereux TR, Lubet RA, You M. 2004. Molecular profiling of mouse lung tumors: association with tumor progression, lung development, and human lung adenocarcinomas. Oncogene 23:1166-1176.
6. Coussens LM, Tinkle CL, Hanahan D, Werb Z. 2000. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103:481-490.
7. Dudoit S, Yang YH, Speed TP, Callow MJ. 2002. Statistical methods for identifying differentially expressed genes in replicated cDNA microarray experiments. Statistica Sinica 12(1):111-139.
8. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfkld CD, Lander ES. 1999. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286:531-537.
9. Hager JH, Hodgson JG, Fridlyand J, Hariono S, Gray JW, Hanahan D. 2004. Oncogene expression and genetic background influence the frequency of DNA copy number abnormalities in mouse pancreatic islet cell carcinomas. Cancer Res 64:2406-2410.
10. Hingorani SR, Wang L, Multani AS, Combs C, Deramaudt TB, Hruban RH, Rustgi AK, Chang S, Tuveson DA. 2005. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7:469-483.
11. Hocevar BA, Mou F, Rennolds JL, Morris SM, Cooper JA, Howe PH. 2003. Regulation of the Wnt signaling pathway by disabled-2 (Dab2). Embo J 22:3084-3094.
12. Hodgson JG, Chin K, Collins C, Gray JW. 2003. Genome amplification of chromosome 20 in breast cancer. Breast Cancer Res Treat 78:337-345.
13. Hughes TR, Marton MJ, Jones AR, Roberts CJ, Stoughton R, Armour CD, Bennett HA, Coffey E, Dai H, He YD, Kidd MJ, King AM, Meyer MR, Slade D, Lum PY, Stepaniants SB, Shoemaker DD, Gachotte D, Chakraburtty K, Simon J, Bard M, Friend SH. 2000. Functional discovery via a compendium of expression profiles. Cell 102(1):109-126.
14. Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, Rozenblum E, Ringner M, Sauter G, Monni O, Elkahloun A and others. 2002. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 62:6240-6245.
15. Johnson L, Mercer K, Greenbaum D, Bronson RT, Crowley D, Tuveson DA, Jacks T. 2001. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410:1111-1116.
16. Kuramochi M, Fukuhara H, Nobukuni T, Kanbe T, Maruyama T, Ghosh HP, Pletcher M, Isomura M, Onizuka M, Kitamura T, Sekiya T, Reeves RH, Murakami Y. 2001. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Nat Genet 27:427-430.
17. Lee JS, Pathak S, Hopwood V, Tomasovic B, Mullins TD, Baker FL, Spitzer G, Neidhart JA. 1987. Involvement of chromosome 7 in primary lung tumor and nonmalignant normal lung tissue. Cancer Res 47:6349-6352.
18. O'Hagan RC, Chang S, Maser RS, Mohan R, Artandi SE, Chin L, DePinho RA. 2002. Telomere dysfunction provokes regional amplification and deletion in cancer genomes. Cancer Cell 2(2):149-155.
19. Phillips JL, Hayward SW, Wang Y, Vasselli J, Pavlovich C, Padilla-Nash H, Pezullo JR, Ghadimi BM, Grossfeld GD, Rivera A, Linehan WM, Cunha GR, Ried T. 2001. The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis. Cancer Res 61:8143-509.
20. Pollack JR, Sorlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE, Tibshirani R, Botstein D, Borresen-Dale AL, Brown PO. 2002. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci USA 99:12963-12968.
21. Silverman B. 1986. Density Estimation for Statistics and Data Analysis. Boca Raton, FL: Chapman & Hall/CRC.
22. Snijders AM, Nowak NJ, Huey B, Fridlyand J, Law S, Conroy J, Tokuyasu T, Demir K, Chiu R, Mao JH and others. 2005. Mapping segmental and sequence variations among laboratory mice using BAC array CGH. Genome Res 15:302-311.
23. Storey J. 2002. A direct approach to false discovery rates. Journal of the Royal Statistical Society Series B 64:479-498.
24. Sweet-Cordero A, Mukherjee S, Subramanian A, You H, Roix JJ, Ladd-Acosta C, Mesirov J, Golub TR, Jacks T. 2004. An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis. Nat Genet.
25. Virtaneva K, Wright FA, Tanner SM, Yuan B, Lemon WJ, Caligiuri MA, Bloomfield CD, de La Chapelle A, Krahe R. 2001. Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc Natl Acad Sci USA 98:1124-1129.
26. Woo RA, Poon RY. 2004. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation. Genes Dev 18:1317-1330.
27. Zhong S, Storch KF, Lipan O, Kao MC, Weitz CJ, Wong WH. 2004. GoSurfer: A graphical interactive tool for comparative analysis of large gene sets in gene ontologytrade mark space. Appl Bioinformatics 3:261-264.